Adaptive Biotechnologies's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Adaptive Biotechnologies (NASDAQ:ADPT) is set to release its quarterly earnings report on November 9, 2023. Analysts estimate an EPS of $-0.34. The company's past performance shows a pattern of share price drops following earnings reports. The stock is currently trading at $4.82, down 49.89% over the last 52-week period.
November 08, 2023 | 4:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Adaptive Biotechnologies is expected to report an EPS of $-0.34. The company's stock has historically dropped following earnings reports. Currently, the stock is trading at $4.82, down 49.89% over the last 52 weeks.
Adaptive Biotechnologies has a history of its stock price dropping following earnings reports. Given the estimated EPS of $-0.34 and the current downward trend of the stock, it is likely that the stock price will continue to decrease in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100